Artículos por temáticas

LRP1 at the crossroads of Parkinson's and Alzheimer's: Divergent roles in α-synuclein and amyloid pathology

Alshahrani SM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Shokr MM, Kadasah SF, Alexiou A, Papadakis M, El-Saber Batiha G.

Eur J Pharmacol. 2025 Sep 5;1002:177830. doi: 10.1016/j.ejphar.2025.177830. Epub 2025 Jun 6.

Black gas, bright future: H(2)S based therapeutics for neurodegenerative disorders

Morris JL, Lee JJ, Morris RE, Miljkovic JL.

Neurotherapeutics. 2025 Sep 24:e00755. doi: 10.1016/j.neurot.2025.e00755. Online ahead of print.

Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromes

Hu MT, Coma AQ, Rowe JB, Zerenner T, Church A, Fumi R, Costantini A, Jabbari E, Jensen MT, Gerhard A, Pavese N, Kobylecki C, Leigh PN, Koychev I, Morris HR, Manohar SG.

Brain. 2025 Sep 3;148(9):3239-3251. doi: 10.1093/brain/awaf132.

Excessive Daytime Sleepiness in Parkinson's Disease and Parkinsonism

Murasan I, Diaconu S, Bougea A, Falup-Pecurariu C.

Sleep Med Clin. 2025 Sep;20(3):333-341. doi: 10.1016/j.jsmc.2025.06.002. Epub 2025 Jul 10.

Parkinson's disease and brain insulin signaling: Mechanisms and potential role of GLP-1 mimetics

Foroozanmehr B, Hemmati MA, Yaribeygi H, Karav S, Jamialahmadi T, Sahebkar A.

Brain Res. 2025 Sep 1;1862:149738. doi: 10.1016/j.brainres.2025.149738. Epub 2025 May 29.

A targeted approach: Gene and RNA editing for neurodegenerative disease treatment

Huang CW, Zhang WZ, Liao Y, Hu T, Li JM, Wang CL.

Life Sci. 2025 Sep 1;376:123756. doi: 10.1016/j.lfs.2025.123756. Epub 2025 May 22.

MicroRNAs and synaptic dysfunction in Parkinson's disease

Ogwo MN, Sharma B, Goyal G, Lakshmanaswamy R, Kumar S.

Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102673. doi: 10.1016/j.omtn.2025.102673. eCollection 2025 Sep 9.

N-acetylcysteine for Parkinson's disease: a translational systematic review of mechanistic and early clinical data

Mohammad A, Ibrahim M, Akram M, Mohsin H, Imran MT, Khan Alizai HN.

Neurodegener Dis Manag. 2025 Sep 24:1-12. doi: 10.1080/17582024.2025.2563489. Online ahead of print.

Micro- and nanoscale biosensing technologies for early diagnosis of Parkinson's disease

Nikam T, Rana A, Saraf SA, Awasthi S.

Mikrochim Acta. 2025 Sep 24;192(10):691. doi: 10.1007/s00604-025-07505-2.

Using Magnetoencephalography to Advance the Science of Parkinson Disease: A Systematic Review

Kariv S, Choi JW, Benam M, Chilukuri S, Alijanpourotaghsara A, Pouratian N.

Brain Behav. 2025 Sep;15(9):e70889. doi: 10.1002/brb3.70889.

The relationship between orthostatic hypotension and cognitive impairment in Parkinson's disease: a systematic review and meta-analysis

Liu Y, Jiang Y, Wang J, Shi Y.

Front Med (Lausanne). 2025 Sep 9;12:1659043. doi: 10.3389/fmed.2025.1659043. eCollection 2025.

Parkinson's disease: genetics and neuroinflammatory insights

Chandel I, Kumari S, Bagri K, Bhatia A, Deshmukh R.

Inflammopharmacology. 2025 Sep;33(9):4997-5009. doi: 10.1007/s10787-025-01832-9. Epub 2025 Jul 3.

Updates on Parkinson's Disease

Bai H, Ma W, Zhu L, Lu Y, Fan J, Chen M, Huang C.

Neuropsychiatr Dis Treat. 2025 Sep 4;21:1945-1953. doi: 10.2147/NDT.S540718. eCollection 2025.

Advances in biosensors for diagnosis of Alzheimer's and Parkinson's diseases

Negahdary M, Sakthinathan I, Mirsadoughi E, Ligler FS, Coté GL, Forster RJ, Mabbott S.

Biosens Bioelectron. 2025 Sep 15;284:117535. doi: 10.1016/j.bios.2025.117535. Epub 2025 May 2.

Three-dimensional midbrain organoids: a next-generation tool for Parkinson's disease modelling and drug discovery

Elvira R, Tan EK, Zhou ZD.

Stem Cell Res Ther. 2025 Sep 25;16(1):502. doi: 10.1186/s13287-025-04660-4.